KALA BIO Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: KALA BIO Inc.
Former names: Kala Pharmaceuticals, Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Arlington
Headquarters state / province: Massachusetts
Headquarters country: United States
Fiscal year end: December
Ticker symbol: KALA
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001479419
EIN: 27-0604595
Wikidata ID: Q30287853

Board of directors

Follow this board

Andrew I. Koven · Director
Since 2023
Avraham Minkowitz · Director · Chief Executive Officer
Since 2026
Brendan P. Purdy · Director
Since 2026
C. Daniel Myers · Director
Since 2023
Chaim D. Berger · Director
Since 2026
David E. Lazar · Director · Chief Executive Officer Overboarded
Since 2025
Gregory D. Perry · Director
Since 2023
Hillel D. Posen · Director
Since 2026
Howard B. Rosen · Director
Since 2023
Marjan Farid · Director
Since 2023
Mark S. Blumenkranz · Director
Since 2023
Mark T. Iwicki · Director · CHIEF EXECUTIVE OFFICER
Since 2023
Todd Bazemore · Director · SEE REMARKS
Since 2025
Yonatan C. Colman · Director
Since 2026

Chief executives

Avraham Minkowitz · Chief Executive Officer

Since January 2026

Mark T. Iwicki · CHIEF EXECUTIVE OFFICER

Until November 2025 · Former

David E. Lazar · Chief Executive Officer

2025 – 2026 · Former

Director election results

Annual meeting of November 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Yonatan C. Colman

99.0%
Brendan P. Purdy

99.0%

Board connections

7 of this board's directors also sit on 17 other boards. 9 are in the same sector.

Shared director Other board Same sector +1 more in the list below

Annexon Inc. Same sector
via Mark S. Blumenkranz
Aterian Inc.
via David E. Lazar
Bio Green Med Solution Inc.
via David E. Lazar
FiEE Inc
via David E. Lazar
Highway Holdings Limited
via David E. Lazar
Indaptus Therapeutics Inc. Same sector
via David E. Lazar
Inhibikase Therapeutics Inc. Same sector
via Mark T. Iwicki
Jade Biosciences Inc. Same sector
via Mark T. Iwicki
LQR House Inc.
via David E. Lazar
MetaVia Inc. Same sector
via Andrew I. Koven
Nova Minerals Corp
via Chaim D. Berger
Pulmatrix Inc. Same sector
via Todd Bazemore
Q32 Bio Inc. Same sector
via Mark T. Iwicki
Quantum Cyber N.V. Same sector
via David E. Lazar
Sow Good Inc.
via David E. Lazar
Stablecoin Development Corporation
via David E. Lazar
Talphera Inc. Same sector
via Howard B. Rosen

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Oct 23, 2025	Mark T. Iwicki Director	Open-market sale	−154,894	$0.81	$125,464
Oct 23, 2025	Reumuth Mary Officer (CHIEF FINANCIAL OFFICER)	Open-market sale	−967	$0.82	$793
Oct 22, 2025	Reumuth Mary Officer (CHIEF FINANCIAL OFFICER)	Open-market sale	−32,230	$0.83	$26,751
Oct 22, 2025	Todd Bazemore Director	Open-market sale	−47,768	$0.83	$39,647
Oct 22, 2025	Brazzell Romulus K Officer (SEE REMARKS)	Open-market sale	−46,748	$0.83	$38,801
Oct 22, 2025	Kharabi Darius Officer (CHIEF BUSINESS OFFICER)	Open-market sale	−20,806	$0.83	$17,269
Oct 1, 2025	Julian Baker Former 10% owner	Open-market sale	−50,640	$1.38	$69,883
Oct 1, 2025	Julian Baker Former 10% owner	Open-market sale	−462,967	$1.38	$638,894
Sep 30, 2025	Julian Baker Former 10% owner	Open-market sale	−21,376	$1.60	$34,202
Sep 30, 2025	Julian Baker Former 10% owner	Open-market sale	−195,425	$1.60	$312,680
Jun 24, 2025	Kharabi Darius Officer (CHIEF BUSINESS OFFICER)	Open-market sale	−4,511	$4.01	$18,089
Jun 24, 2025	Reumuth Mary Officer (CHIEF FINANCIAL OFFICER)	Open-market sale	−3,631	$4.01	$14,560
Jun 24, 2025	Todd Bazemore Officer (SEE REMARKS)	Open-market sale	−4,058	$4.01	$16,273
Jun 24, 2025	Brazzell Romulus K Officer (SEE REMARKS)	Open-market sale	−5,251	$4.01	$21,057
Jun 24, 2025	Mark T. Iwicki Director	Open-market sale	−13,227	$4.01	$53,040

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about KALA BIO Inc.

Who is the CEO of KALA BIO Inc.?

Avraham Minkowitz has been KALA BIO Inc.'s Chief Executive Officer since January 2026.

How many directors are on KALA BIO Inc.'s board?

KALA BIO Inc.'s board has 14 directors: Andrew I. Koven, Avraham Minkowitz, Brendan P. Purdy, C. Daniel Myers, Chaim D. Berger, David E. Lazar, Gregory D. Perry, Hillel D. Posen, Howard B. Rosen, Marjan Farid and 4 others.

How is KALA BIO Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="kala-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.